Cardiovascular disease (CVD) includes the diseases of the heart and the circulatory system. The clinical manifestations can be divided into groups that affect different parts of the human body, such as:

  • Heart and circulatory system, or coronary heart disease;
  • Brain and cerebral vascular system, or cerebrovascular disease;
  • Lower limbs, or peripheral artery disease.


Enter your email address:

At the base of all these diseases is usually atherosclerosis, or damage of the arteries. It’s characterized by narrowing of the lumen of the vessels, due to local thickening of the inner layer of the vessel wall. This type of thickening is known as atheroma, or plaque. Atheroma consists a core made of lipids, particularly cholesterol and degraded cells, covered with a binder and calcium, making the vessel wall hard and inelastic at the affected area. Atherosclerotic buildup narrows the arteries, so the tissues they supply, get less blood. Also, due to the decrease of elasticity, it can come to a rupture of the blood vessels, which manifests as one of the aforementioned diseases.

Hypertension is a separate disease of the cardiovascular system, a risk factor for the development of other cardiovascular diseases.

Why Do Cardiovascular Diseases Develop? What Are The Risk Factors?

Decades ago, epidemiological studies have shown that there are many so-called risk factors for atherosclerosis and other diseases of the heart and blood vessels. These risk factors consist of the specific features of a person and its lifestyle habits, associated with atherosclerosis and its progress. The development of a certain disease is particularly accelerated if a person has multiple risk factors simultaneously. Thus, it can be very dangerous if we have more than one risk factor.

Some risk factors we can influence, others we cannot. Among those that we can affect, are:

  • Smoking
  • Hypertension
  • Increased lipid levels in the blood (cholesterol and triglycerides)
  • Obesity
  • Lack of physical activity

Risk factors that we cannot influence include:

  • Age and gender (men above 45 years of age; women above 55 years of age)
  • Hereditary factors (positive family history) – premature death, due to coronary heart disease, of close male relatives aged 55; or close female family members aged 65.
Prevention With Lemon – Garlic Mixture

According to a study published on the site of the National Center for Biotechnology Information, lemon and garlic can be very beneficial in the prevention of cardiovascular diseases. Namely, when these two ingredients are combined together, they help reduce the lipid levels in the blood and positively influence some cardiovascular risk factors.

The study was performed on 112 people, suffering from hyperlipidemia, from 30 to 60 years of age. They were divided into 4 separate groups, observed in the course of 8 consequential weeks. The participants of the first group were given 1 tbsp. of fresh lemon juice and 20g of minced garlic, each day. The second group was consuming only 20g of garlic, while the third group only lemon juice. The fourth group wasn’t consuming neither garlic nor lemon juice. All participants took a blood sample test before and after the study. Also, their blood pressure levels, weight and height were measured.

The end results of the participants in the first group, when compared to the other three, showed a noticeable decrease in the total cholesterol levels and the LDL cholesterol. Also, they had a significant decrease in fibrinogen, a protein that helps blood clots to form.

In regards to the diastolic and systolic blood pressure, the first group showed greater reduction than the third and fourth group. In addition, they also showed a greater reduction in the body mass index.

Conclusion: Daily consumption of this lemon – garlic mixture can improve your lipid levels, blood pressure and fibrinogen. Thus, if you’re at risk of developing cardiovascular diseases, start consuming it instantly!

Effect of Garlic and Lemon Juice Mixture on Lipid Profile and Some Cardiovascular Risk Factors in People 30-60 Years Old with Moderate Hyperlipidaemia: A Randomized Clinical Trial